SI8012952A8 - Process for obtaining cephalosporin derivatives - Google Patents

Process for obtaining cephalosporin derivatives Download PDF

Info

Publication number
SI8012952A8
SI8012952A8 SI8012952A SI8012952A SI8012952A8 SI 8012952 A8 SI8012952 A8 SI 8012952A8 SI 8012952 A SI8012952 A SI 8012952A SI 8012952 A SI8012952 A SI 8012952A SI 8012952 A8 SI8012952 A8 SI 8012952A8
Authority
SI
Slovenia
Prior art keywords
salts
compound
formula
salt
hydrate
Prior art date
Application number
SI8012952A
Other languages
English (en)
Slovenian (sl)
Inventor
Marco Montavon
Roland Reiner
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SI8012952A8 publication Critical patent/SI8012952A8/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Table Devices Or Equipment (AREA)
  • Laminated Bodies (AREA)
  • Suspension Of Electric Lines Or Cables (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Peptides Or Proteins (AREA)
SI8012952A 1979-11-21 1980-11-20 Process for obtaining cephalosporin derivatives SI8012952A8 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1038479 1979-11-21
YU2952/80A YU42364B (en) 1979-11-21 1980-11-20 Process for producing cephalosporine derivative

Publications (1)

Publication Number Publication Date
SI8012952A8 true SI8012952A8 (en) 1997-06-30

Family

ID=4362652

Family Applications (1)

Application Number Title Priority Date Filing Date
SI8012952A SI8012952A8 (en) 1979-11-21 1980-11-20 Process for obtaining cephalosporin derivatives

Country Status (21)

Country Link
EP (1) EP0030294B1 (fr)
JP (2) JPS5692894A (fr)
KR (1) KR860000852B1 (fr)
AT (1) ATE8896T1 (fr)
AU (1) AU533088B2 (fr)
CA (1) CA1146165A (fr)
DE (1) DE3068905D1 (fr)
DK (1) DK166728B1 (fr)
ES (2) ES496994A0 (fr)
FI (2) FI67385C (fr)
GR (1) GR71879B (fr)
HU (1) HU184941B (fr)
IE (1) IE50516B1 (fr)
IL (1) IL61486A (fr)
NO (2) NO166229C (fr)
NZ (1) NZ195547A (fr)
PH (2) PH17359A (fr)
PT (1) PT72084B (fr)
SI (1) SI8012952A8 (fr)
YU (1) YU42364B (fr)
ZA (1) ZA807099B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0830051B2 (ja) * 1986-05-21 1996-03-27 武田薬品工業株式会社 ４−ハロゲノ−２−置換オキシイミノ−３−オキソ酪酸のエステルまたはアミドの製造法
JP2595605B2 (ja) * 1988-01-18 1997-04-02 武田薬品工業株式会社 ２−置換オキシイミノ−３−オキソ酪酸の製造法
AT398764B (de) * 1992-01-28 1995-01-25 Lek Tovarna Farmacevtskih Verfahren zur herstellung von ceftriaxondinatrium-salzhemiheptahydrat
AT399877B (de) * 1992-02-20 1995-08-25 Biochemie Gmbh Neues verfahren zur herstellung von ceftriaxon
AT411598B (de) * 1999-04-29 2004-03-25 Biochemie Gmbh Verfahren zur herstellung von cephalosporinen
AT408225B (de) * 1999-04-29 2001-09-25 Biochemie Gmbh Verfahren zur herstellung von cephalosporinen
WO2003004477A1 (fr) * 2001-06-14 2003-01-16 Orchid Chemicals & Pharmaceuticals Limited 1,3,4-oxadiazol-2-yl thioesters et leur utilisation pour l'acylation de 7-aminocephalosporines
IN192139B (fr) 2001-11-26 2004-02-21 Lupin Ltd
US6919449B2 (en) 2002-04-19 2005-07-19 Orchid Chemicals And Pharmaceuticals Limited Process for the preparation of cephalosporin intermediate and its use for the manufacture of cephalosporin compounds
WO2003089406A1 (fr) * 2002-04-19 2003-10-30 Orchid Chemicals And Pharmaceuticals Limited Procede de preparation d'un produit intermediaire de cephalosporine et son utilisation pour la fabrication de composes de cephalosporine
US6800756B2 (en) * 2002-05-03 2004-10-05 Orchid Chemicals And Pharmaceuticals, Ltd. Method for the preparation of ceftiofur sodium and its intermediates
WO2004083216A1 (fr) * 2003-03-20 2004-09-30 Orchid Chemicals & Pharmaceuticals Ltd Procede de preparation de cephalosporines
PL1618114T3 (pl) 2003-04-16 2010-12-31 Sandoz Ag Sposoby otrzymywania cefepimy
US7847093B2 (en) 2003-04-16 2010-12-07 Sandoz Ag Processes for the preparations of cefepime
US7098329B2 (en) * 2003-06-19 2006-08-29 Orchid Chemicals & Pharmaceuticals Ltd. Process for the preparation of a cephalosporin antibiotic
WO2005019227A1 (fr) 2003-08-22 2005-03-03 Orchid Chemicals & Pharmaceuticals Ltd Procede de preparation d'un antibiotique a base de cephalosporine
US20050059820A1 (en) * 2003-09-17 2005-03-17 Debashish Datta Method for manufacture of ceftriaxone sodium
WO2005040175A2 (fr) * 2003-10-22 2005-05-06 Ranbaxy Laboratories Limited Procede de preparation d'acides carboxyliques de type cephem
US20050119244A1 (en) 2003-12-02 2005-06-02 Acs Dobfar S.P.A. Process for preparing cephalosporins with salified intermediate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200745A (en) * 1977-12-20 1980-04-29 Eli Lilly And Company 7[2-(2-Aminothiazol-4-yl)-2-alkoxyimino]acetamido 3[4-alkyl-5-oxo-6-hydroxy-3,4 dihydro 1,2,4-triazin 3-yl]thio methyl cephalosporins
JPS5498795A (en) * 1978-01-13 1979-08-03 Takeda Chem Ind Ltd Cephalosporin derivative and its preparation
MC1259A1 (fr) * 1978-05-30 1980-01-14 Hoffmann La Roche Derives acyles

Also Published As

Publication number Publication date
ATE8896T1 (de) 1984-08-15
JPS61143392A (ja) 1986-07-01
FI842614A0 (fi) 1984-06-28
IL61486A (en) 1984-04-30
HU184941B (en) 1984-11-28
YU42364B (en) 1988-08-31
KR860000852B1 (ko) 1986-07-09
JPH0248559B2 (fr) 1990-10-25
PH18468A (en) 1985-07-18
NO812083L (no) 1981-12-22
ES8200694A1 (es) 1981-11-16
ES503583A0 (es) 1982-06-01
YU295280A (en) 1983-06-30
KR830004315A (ko) 1983-07-09
IE802408L (en) 1981-05-21
FI793768A (fi) 1981-05-22
GR71879B (fr) 1983-08-03
IE50516B1 (en) 1986-04-30
NO803516L (no) 1981-05-22
FI67385C (fi) 1985-03-11
PT72084A (en) 1980-12-01
FI71563C (fi) 1987-01-19
NO166228C (no) 1991-06-19
NO166229B (no) 1991-03-11
JPS5692894A (en) 1981-07-27
NO166228B (no) 1991-03-11
DE3068905D1 (en) 1984-09-13
AU533088B2 (en) 1983-10-27
PH17359A (en) 1984-08-01
FI71563B (fi) 1986-10-10
FI67385B (fi) 1984-11-30
PT72084B (en) 1982-07-30
EP0030294A3 (en) 1981-12-09
CA1146165A (fr) 1983-05-10
DK166728B1 (da) 1993-07-05
ES8204997A1 (es) 1982-06-01
JPS6145995B2 (fr) 1986-10-11
NO166229C (no) 1991-06-19
FI842614A (fi) 1984-06-28
EP0030294A2 (fr) 1981-06-17
NZ195547A (en) 1983-05-10
ES496994A0 (es) 1981-11-16
AU6443880A (en) 1981-05-28
ZA807099B (en) 1981-11-25
EP0030294B1 (fr) 1984-08-08
DK496380A (da) 1981-05-22
IL61486A0 (en) 1980-12-31

Similar Documents

Publication Publication Date Title
SI8012952A8 (en) Process for obtaining cephalosporin derivatives
CH634578A5 (de) Verfahren zur herstellung von neuen cephalosporinderivaten.
JPS59172493A (ja) 化合物
PL172835B1 (pl) Chlorowodorek kwasu 7- ß -[(Z)-2-(2-amino-4-tiazolilo)-2-hydroksyiminoacetamido]-3-(1,2,3-triazol-4-ilo)-tiometylotio-3 -cefemo-4-karboksylowego oraz sposób jego wytwarzania, krystaliczny wodzian chlorowodorku kwasu 7- ß -(Z)-2-(2-amino-4-tiazolilo)-2-hydroksyiminoacetamido]-3-(1,2,3-triazol-4-ilo)-tiometylotio-3-ce- femo-4-karboksylowego oraz sposób jego wytwarzania PL PL PL PL PL
EP0134420B1 (fr) Dérivés de céphalosporines, leur préparation et compositions pharmaceutiques
JPS5686187A (en) 7-acylamino-3-vinylcephalosporanic acid derivative and its preparation
US3880848A (en) 7-Trifluorome thylsulfinylacetamido cephalosporins
JPH01216995A (ja) 結晶化したセフェム−酸付加塩およびそれらの製法
PL109311B1 (en) Method of producing stabilized sodium salt of 7-/d-2-formyloxy-2-phenyloacetamido/-3-/methylo-1h-tetrazolylo-5-thiomethylo/-3-cephemocarboxylic-4 acid
JPS6123197B2 (fr)
JPH09507473A (ja) キレート化剤としてのｎ，ｎ′−ビス（２−ヒドロキシベンジル）エチレンジアミン−ｎ，ｎ′−ジ酢酸誘導体
DE3784778T2 (de) Cephemverbindungen, ihre herstellung und anwendung.
KR0174117B1 (ko) 새로운 세팔로스포린 유도체 및 그 제조방법
JPH0324477B2 (fr)
JPS5931796A (ja) Ｄｍｔのｃ−２３−修飾誘導体
EP0159011B1 (fr) Dérivés de céphalosporine, procédé pour leur préparation et compositions pharmaceutiques les contenant
US3943128A (en) 7-Trifluoromethylsulfinylacetamido cephalosporins
KR840001826B1 (ko) 1-옥사데티아세팔로스포린 유도체의 제조방법
US4626533A (en) 7-(2-thienylacetamido)-3-acylaminomethyl-cephalosporins
US3943127A (en) 7-Trifluoromethylsulfinylacetamido cephalosporins
US3082253A (en) Complexes of tetracycline antibiotics and preparation of same
CS236000B2 (cs) Způsob přípravy nových derivátů pyridiniumthiomethylcefalosporinů
JPS6259708B2 (fr)
JPH03232891A (ja) 新規な３―イソオキサゾリジニルセファロスポリン誘導体
JPS57139082A (en) Acid addition salt of cephalosporin derivative